Newell Rubbermaid Inc. — FY2015 Form 10-K
Reporting period: Fiscal year ended December 31, 2015; filed February 29, 2016. This is an annual filing, not a standalone fourth-quarter filing. The company markets consumer and commercial products across Writing, Home Solutions, Tools, Commercial Products, and Baby & Parenting.
Financial performance
| Metric | FY2015 | FY2014 |
|---|---|---|
| Net sales | $5,915.7 million | $5,727.0 million |
| Gross margin | $2,304.6 million; 39.0% | $2,203.4 million; 38.5% |
| Operating income | $601.4 million; 10.2% margin | $604.7 million; 10.6% margin |
| Continuing-operations income | $259.3 million | $373.0 million |
| Net income | $350.0 million | $377.8 million |
| Diluted EPS | $1.29 | $1.35 |
| Operating cash flow | $565.8 million | $634.1 million |
| Capital expenditures | $211.4 million | $161.9 million |
| Total debt at year-end | $3,076.4 million | $2,481.9 million |
Cash and equivalents were $274.8 million; working capital was $504.9 million and the current ratio was 1.25. The company reported $800 million of available capacity under its revolving facility and $50 million under its receivables facility. Net debt to total capitalization was 0.61, versus 0.55 a year earlier. Quarterly dividends totaled $0.76 per share for 2015.
Fourth-quarter net sales were $1,560.8 million. Continuing operations recorded a $79.7 million loss, while net income was $13.2 million, reflecting $92.9 million of income from discontinued operations, primarily related to the Endicia sale. The continuing-operations loss included significant unusual charges, including the Venezuela deconsolidation charge.
Changes versus prior year
- Reported sales rose 3.3%; core sales, a company-defined non-GAAP measure excluding currency, acquisitions, and planned or completed divestitures, grew 5.5%. Foreign exchange reduced reported sales by $331 million, or 5.8 percentage points; acquisitions added 4.7 points and divestitures reduced growth by 1.1 points.
- Gross margin expanded 50 basis points, aided by productivity, pricing, lower input costs, and comparison with the prior-year Graco recall effects. Operating margin fell 40 basis points as SG&A and restructuring costs rose.
- Continuing-operations income fell to $259.3 million from $373.0 million. FY2015 included a $172.7 million pretax Venezuela deconsolidation charge, higher interest expense, a $52.1 million noncash pension settlement charge, and $77.2 million of restructuring costs. Net income was partly supported by $90.7 million of discontinued-operations income, largely reflecting the Endicia sale gain.
- Segment sales increased in Writing (3.2%), Home Solutions (8.2%), and Baby & Parenting (12.6%); declined in Tools (7.3%) and Commercial Products (3.3%). Acquisitions and currency materially affected reported segment comparisons.
- Operating cash flow declined $68.3 million, principally reflecting pension funding, inventory investment, project costs, and lower cash provided by accounts payable.
Outlook, strategy, risks, and unusual items
- Management expected to move into the Acceleration Phase of its Growth Game Plan in 2016, emphasizing brand investment, innovation, and growth in selected businesses. No specific consolidated 2016 revenue or earnings guidance is provided in the filing text.
- Project Renewal was expected to produce annualized savings of $620–$675 million by the end of 2017, including savings expected in 2018 from projects completed in 2017. The company had realized approximately $360 million in annualized savings by year-end 2015; cumulative program costs were estimated at $690–$725 million. Management said most savings would be reinvested in brand building and selling capabilities.
- The proposed Jarden acquisition was expected to close in the second quarter of 2016, subject to shareholder, regulatory, and other approvals. Consideration was 0.862 Newell Rubbermaid share plus $21 cash per Jarden share. The filing estimated approximately $14 billion in total consideration and about $14 billion of combined-company debt after closing; management anticipated approximately $500 million in annualized cost synergies over four years. Financing, integration, leverage, credit-rating, and closing risks are significant.
- Venezuela’s currency restrictions, pricing controls, and other government measures led the company to deconsolidate its subsidiary on December 31, 2015, recording a $172.7 million pretax charge. From 2016, Venezuelan results would no longer be consolidated.
- Other key risks include strong retailer bargaining power and customer consolidation, foreign-exchange exposure, input and sourced-product inflation, reliance on single-source suppliers (notably in Baby & Parenting), product liability and recalls, pension funding needs, tax contingencies, and potential environmental liabilities. The company disclosed a Lower Passaic River matter for which its ultimate responsibility could not yet be estimated; it stated that an adverse outcome could be material.
Investor verification priorities
- Reconcile underlying sales and operating trends with reported results, particularly currency effects, acquisition contributions, planned divestitures, and the unusually strong Latin America/Venezuela contribution to core growth.
- Assess the quality and repeatability of earnings excluding the Venezuela charge, pension settlement, restructuring, and Endicia gain; review the fourth-quarter continuing-operations loss in detail.
- Verify Project Renewal savings, remaining implementation costs, timing, and whether savings are reinvested or improve margins and cash flow.
- Track Jarden transaction approvals, final financing terms, post-close debt reduction, investment-grade ratings, realized synergies, and integration costs.
- Review liquidity and near-term maturities alongside inventory and working-capital trends, pension obligations, tax exposures, and unresolved environmental and product-liability matters.